p70(s6k)/NN
integrates/VBZ
phosphatidylinositol/NN
3-kinase/NN
and/CC
rapamycin-regulated/JJ
signals/NNS
for/IN
E2F/NN
regulation/NN
in/IN
T/NN
lymphocytes/NNS
./.

In/IN
T/NN
lymphocytes/NNS
,/,
the/DT
hematopoietic/JJ
cytokine/NN
interleukin-2/NN
(/(
IL-2/NN
)/)
uses/VBZ
phosphatidylinositol/NN
3-kinase/NN
(/(
PI/NN
3-kinase/NN
)/)
-induced/JJ
signaling/NN
pathways/NNS
to/TO
regulate/VB
E2F/NN
transcriptional/JJ
activity/NN
,/,
a/DT
critical/JJ
cell/NN
cycle/NN
checkpoint/NN
./.
=====
PI/NN
3-kinase/NN
also/RB
regulates/VBZ
the/DT
activity/NN
of/IN
p70(s6k)/NN
,/,
the/DT
40S/JJ
ribosomal/JJ
protein/NN
S6/NN
kinase/NN
,/,
a/DT
response/NN
that/WDT
is/VBZ
abrogated/VBN
by/IN
the/DT
macrolide/NN
rapamycin/NN
./.
=====
This/DT
immunosuppressive/JJ
drug/NN
is/VBZ
known/VBN
to/TO
prevent/VB
T-cell/NN
proliferation/NN
,/,
but/CC
the/DT
precise/JJ
point/NN
at/IN
which/WDT
rapamycin/NN
regulates/VBZ
T-cell/NN
cycle/NN
progression/NN
has/VBZ
yet/RB
to/TO
be/VB
elucidated/VBN
./.
=====
Moreover/RB
,/,
the/DT
effects/NNS
of/IN
rapamycin/NN
on/IN
,/,
and/CC
the/DT
role/NN
of/IN
p70(s6k)/NN
in/IN
,/,
IL-2/NN
and/CC
PI/NN
3-kinase/NN
activation/NN
of/IN
E2Fs/NNS
have/VBP
not/RB
been/VBN
characterized/VBN
./.
=====
Our/PRP$
present/JJ
results/NNS
show/VBP
that/IN
IL-2-/NN
and/CC
PI/NN
3-kinase-induced/JJ
pathways/NNS
for/IN
the/DT
regulation/NN
of/IN
E2F/NN
transcriptional/JJ
activity/NN
include/VBP
both/CC
rapamycin-resistant/JJ
and/CC
rapamycin-sensitive/JJ
components/NNS
./.
=====
Expression/NN
of/IN
a/DT
rapamycin-resistant/JJ
mutant/NN
of/IN
p70(s6k)/NN
in/IN
T/NN
cells/NNS
could/MD
restore/VB
rapamycin-suppressed/JJ
E2F/NN
responses/NNS
./.
=====
Thus/RB
,/,
the/DT
rapamycin-controlled/JJ
processes/NNS
involved/VBN
in/IN
E2F/NN
regulation/NN
appear/VBP
to/TO
be/VB
mediated/VBN
by/IN
p70(s6k)/NN
./.
=====
However/RB
,/,
the/DT
rapamycin-resistant/JJ
p70(s6k)/NN
could/MD
not/RB
rescue/VB
rapamycin/NN
inhibition/NN
of/IN
T-cell/NN
cycle/NN
entry/NN
,/,
consistent/JJ
with/IN
the/DT
involvement/NN
of/IN
additional/JJ
,/,
rapamycin-sensitive/JJ
pathways/NNS
in/IN
the/DT
control/NN
of/IN
T-cell/NN
cycle/NN
progression/NN
./.
=====
The/DT
present/JJ
results/NNS
thus/RB
show/VBP
that/IN
p70(s6k)/NN
is/VBZ
able/JJ
to/TO
regulate/VB
E2F/NN
transcriptional/JJ
activity/NN
and/CC
provide/VB
direct/JJ
evidence/NN
for/IN
the/DT
first/JJ
time/NN
for/IN
a/DT
link/NN
between/IN
IL-2/NN
receptors/NNS
,/,
PI/NN
3-kinase/NN
,/,
and/CC
p70(s6k)/NN
that/WDT
regulates/VBZ
a/DT
crucial/JJ
G1/NN
checkpoint/NN
in/IN
T/NN
lymphocytes/NNS
./.